Igs7tm140.1(tetO-EGFP,CAG-tTA2)Hze
Targeted Allele Detail
|
Symbol: |
Igs7tm140.1(tetO-EGFP,CAG-tTA2)Hze |
Name: |
intergenic site 7; targeted mutation 140.1, Hongkui Zeng |
MGI ID: |
MGI:5904001 |
Synonyms: |
Ai140D, Ai140(TIT2L-GFP-ICL-tTA2)-D |
Gene: |
Igs7 Location: unknown Genetic Position: Chr9, Syntenic
|
Alliance: |
Igs7tm140.1(tetO-EGFP,CAG-tTA2)Hze page
|
|
|
Allele Type: |
|
Targeted (Conditional ready, Inducible, Reporter, Transactivator) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Mutation details: The replacement vector is designed with (from 5' to 3') an FRT3 site, two copies of chicken beta-globin HS4 insulator element, a Tet response element/promoter (TRE2), a loxP-flanked STOP cassette, a synthetic enhanced green fluorescent protein sequence (EGFP), a woodchuck hepatitis virus post-transcriptional regulatory element, a BGH polyA, two copies of chicken beta-globin HS4 insulator element, a CMV-IE enhancer/chicken beta-actin/rabbit beta-globin hybrid promoter (CAG; from pCAGGS), a lox2272-flanked STOP cassette, a synthetic modified tetracycline-regulated transactivator gene (tTA2S), a WPRE, a BGH polyA, an AttB site, a PGK-5'hygro cassette, an RNA splice donor and a FRT5 site. Embryonic stem cells previously targeted with FRT3::AttB::PGK-neoR-polyA::FRT5::splice acceptor::3'hygro cassette::SV40 polyA:AttP in TIGRE, were re-transfected with the pTRE2-LSL-EGFP-CAG-LSL-tTA2 replacement vector and Flp recombinase vector for recombinase-mediated cassette exchange (RCME). PhiC31-mediated recombination removed the AttB/AttP-flanked sequence (PGK-Neo-polyA::frt5::RNA splice acceptor::3'hygro-polyA) and replaced it with the recombined AttB/AttP site (AttL).
(J:101977, J:260362)
|
|
|
|
Original: |
J:101977 The Jackson Laboratory, Information obtained from The Jackson Laboratory, Bar Harbor, ME. Unpublished. 2005-2017; |
All: |
14 reference(s) |
|